Showing 601 - 620 results of 693 for search '"Parkinson's disease"', query time: 0.06s Refine Results
  1. 601

    Hsp70 and Its Molecular Role in Nervous System Diseases by Giuseppina Turturici, Gabriella Sconzo, Fabiana Geraci

    Published 2011-01-01
    “…Hsp70 functions as a chaperone and protects neurons from protein aggregation and toxicity (Parkinson disease, Alzheimer disease, polyglutamine diseases, and amyotrophic lateral sclerosis), protects cells from apoptosis (Parkinson disease), is a stress marker (temporal lobe epilepsy), protects cells from inflammation (cerebral ischemic injury), has an adjuvant role in antigen presentation and is involved in the immune response in autoimmune disease (multiple sclerosis). …”
    Get full text
    Article
  2. 602

    Health Benefits of Endurance Training: Implications of the Brain-Derived Neurotrophic Factor—A Systematic Review by Włodzimierz Mrówczyński

    Published 2019-01-01
    “…Thus, this report presents the influence of endurance exercises on the (1) transformation of motoneuron properties, which are a final element of the motor pathways, (2) reduction of motor deficits evoked by Parkinson disease, and (3) prevention of the metabolic syndrome (MetS). …”
    Get full text
    Article
  3. 603

    The Influence of Playing a Non-Reward Game on Motor Ability and Executive Function in Parkinson’s Disease by Alisson Menezes Araújo Lima, Fabiana de Campos Cordeiro Hirata, Gabriela Sales de Bruin, Rosa Maria Salani Mota, Veralice Meireles Sales de Bruin

    Published 2012-01-01
    “…The aim of this study is to evaluate the acute effect of playing games on executive function and motor ability in Parkinson's disease (PD). Consecutive cases with PD were studied with the Unified Parkinson Disease Rating Scale (UPDRS), Mini-Mental State examination (MMSE), Beck Depression Inventory (BDI), Stroop test, finger tapping and 14-meter walk test. …”
    Get full text
    Article
  4. 604

    Impairments in Deductive Reasoning and Working Memory in Parkinson’s Disease by Shelley Channon

    Published 1997-01-01
    “…This study was designed to investigate the nature and extent of executive impairments in medicated subjects with Parkinson's disease (PD) and matched control subjects. They performed two tasks involving strategic processing, deductive reasoning and memory updating. …”
    Get full text
    Article
  5. 605

    Research hotspots and trends in the antioxidant effects of acupuncture: A bibliometric analysis from 2003 to 2024 by Zhilin Huang, Song Li, YiHao Zhou, Anhong Dai, Yi Zhang, Meifang Liu, Mengqi Le, Jing Shi

    Published 2025-03-01
    “…Neurological disorders such as Parkinson's disease, vascular dementia, and stroke are major research areas in this field. …”
    Get full text
    Article
  6. 606

    Dual Task Performance in Parkinson’s Disease by Jennifer A. Foley, Reiner Kaschel, Sergio Della Sala

    Published 2013-01-01
    “…It is not known if this deficit is specific to AD, or also present in other neurodegenerative disorders that can occur in later life, such as Parkinson's disease (PD). Therefore, this study investigated dual tasking in 13 people with PD, 26 AD and 42 healthy age-matched controls. …”
    Get full text
    Article
  7. 607

    Investigating a Case of Recurrent Pleural Effusion by Patrícia Rodrigues, Maria Neves, João Pedro Ferreira, Miguel Araújo Abreu, Fernanda Almeida

    Published 2011-01-01
    “…We describe the case of a patient with long-standing Parkinson's disease and recurrent bilateral pleural effusions. …”
    Get full text
    Article
  8. 608

    Anxiety and Depression in Parkinson’s Disease by S. E. Starkstein, R. G. Robinson, R. Leiguarda, T. J. Preziosi

    Published 1993-01-01
    “…We examined a consecutive series of 40 patients with Parkinson's disease (PD) for the presence of anxiety. We found that 40 % met DSM-III criteria for generalized anxiety disorders, and half of them also met criteria for either major depression or minor depression. …”
    Get full text
    Article
  9. 609

    Facial Expressions and Parkinson’s Disease by P. Madeley, A. W. Ellis, R. H. S. Mindham

    Published 1995-01-01
    “…Patients with Parkinson's disease (PD) and matched control subjects were photographed posing a range of facial expressions. …”
    Get full text
    Article
  10. 610

    Anesthesia for Pediatric Deep Brain Stimulation by Joseph Sebeo, Stacie G. Deiner, Ron L. Alterman, Irene P. Osborn

    Published 2010-01-01
    “…In patients refractory to medical therapy, deep brain stimulations (DBSs) have emerged as the treatment of movement disorders particularly Parkinson's disease. Their use has also been extended in pediatric and adult patients to treat epileptogenic foci. …”
    Get full text
    Article
  11. 611

    Event Related Potentials and Serial List Picture Memory in Parkinson’s Patients by M. S. Korsnes, I. Reinvang

    Published 1996-01-01
    “…Two experiments examined short-term memory for order information in six patients diagnosed with Parkinson's disease (PD) and six control subjects while event related potentials (ERPs) were recorded. …”
    Get full text
    Article
  12. 612

    Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application by Dorit Trudler, Dorit Farfara, Dan Frenkel

    Published 2010-01-01
    “…This paper will focus on TLR signaling in glial cells in neurodegenerative diseases such as Alzheimer's disease, prion diseases, amyotrophic lateral sclerosis, and Parkinson's disease. Understanding the pattern of TLR signaling in the glial cells may lead to the identification of new targets for therapeutic application.…”
    Get full text
    Article
  13. 613

    PPAR Regulation of Inflammatory Signaling in CNS Diseases by John J. Bright, Saravanan Kanakasabai, Wanida Chearwae, Sharmistha Chakraborty

    Published 2008-01-01
    “…Specific ligands for PPAR𝛼, 𝛾, and 𝛿 isoforms have proven effective in the animal models of multiple sclerosis (MS), Alzheimer's disease, Parkinson's disease, and trauma/stroke, suggesting their use in the treatment of neuroinflammatory diseases. …”
    Get full text
    Article
  14. 614

    Summary of Proprioceptive Training on Motor Dysfunction Rehabilitation by Renxin JI, Wenhua CHEN, Qi QI

    Published 2017-04-01
    “…Whole body vibration of somatosensory stimulation training was the most effective form to improve motor dysfunction caused by dystonia in patients with Parkinson's disease. Proprioception training had got more and more attention on rehabilitation of patients with a variety of motor dysfunction.…”
    Get full text
    Article
  15. 615

    Clock-Drawing in Neurological Disorders by Gerald Dal Pan, Yaakov Stern, Mary Sano, Richard Mayeux

    Published 1989-01-01
    “…Non-demented patients with Parkinson's disease showed only defects in the spatial organization of the numbers, and non-demented patients with other diseases perform as well as controls.…”
    Get full text
    Article
  16. 616

    Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement by Walavan Sivakumar, Sarah T. Garber, Lauren E. Schrock, Paul A. House

    Published 2013-01-01
    “…The authors report a case of a man who presented with delayed, recurrent intracranial hemorrhage months after successful deep brain stimulator placement for Parkinson disease while on edoxaban for atrial fibrillation. …”
    Get full text
    Article
  17. 617

    MRI Findings in Neuroferritinopathy by Emiko Ohta, Yoshihisa Takiyama

    Published 2012-01-01
    “…Based on observations of an excessive iron content in patients with chronic neurologic disorders, such as Parkinson disease and Alzheimer disease, the presence of excess iron is therefore recognized as a major risk factor for neurodegenerative diseases. …”
    Get full text
    Article
  18. 618

    Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia by Justine Chan, Paarth Shah, Guillermo Moguel-Cobos

    Published 2019-01-01
    “…This agent is also being studied in neurodegenerative disorders including Parkinson disease. Studies have shown that nilotinib may decrease the accumulation of parkin substrates and decrease the loss of dopaminergic cells. …”
    Get full text
    Article
  19. 619

    Electroconvulsive treatment of a patient with Parkinson’s disease and moderate depression by John Erik Berg

    Published 2011-02-01
    “…Electroconvulsive treatment should be offered to more patients with Parkinson disease and depression in order to lessen the burden of both depression and Parkinson symptoms.…”
    Get full text
    Article
  20. 620

    Role of the Striatum and the Cerebellum in Motor Skill Acquisition by Markus M. Schugens, Caterina Breitenstein, Hermann Ackermann, Irene Daum

    Published 1999-01-01
    “…Motor skill acquisition was investigated in patients with Parkinson's disease (PD) or cerebellar dysfunction using two sensory-guided tracking tasks. …”
    Get full text
    Article